Cancer52 prepares briefing for debate on a future cancer strategy for England
Cancer52 has prepared a briefing for a Westminster Hall Debate on the ‘Potential merits of a cancer strategy for England’ . The debate...
top of page
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...
National Data Opt-out and what it means to cancer patients
Cancer52, together with use MY data, has produced a briefing paper entitled National Data Opt-out and what it means to cancer patients....
Cancer Strategy recommendations grid April
As at April 2017, Cancer52 has published a review of the progress of the recommendations contained in ‘Achieving World Class Cancer...
Briefing paper on the New Cancer Drug Fund Operating Model
On 28th July 2016 Cancer52 published its Cancer52 Position Paper on the new Cancer Drugs Fund Operating Model FINAL 28th July 2016.
Briefing paper on England Cancer Strategy Implementation Plan
On 22nd June 2016 Cancer52 published its Cancer52 position statement Cancer Implementation Plan June 2016 FINAL.
Briefing paper on Access to Medicines and Treatments
On 23rd December 2015, Cancer52 published its Briefing Paper on Access to Medicines and Treatments.
Policy briefing on Achieving World Class Outcomes
A briefing on the implementation of Achieving World Class Outcomes: A Strategy for England 2015-2020.
Briefing paper on Access to Orphan Medicines in the UK
On 5th June 2014, Cancer52 published its Briefing Paper on Access to Orphan Medicines in the UK.
Briefing paper on the UK Strategy for Rare Diseases: Making sure that rare cancers aren’t written ou
On 24th February 2014, Cancer52 published its Briefing Paper on the UK Strategy for Rare Diseases.
bottom of page